메뉴 건너뛰기




Volumn 404, Issue 10, 2012, Pages 2939-2948

Speciation of antimony in injectable drugs used for leishmaniasis treatment (Glucantime®) by HPLC-ICP-MS and DPP

Author keywords

Antimony; DPP; Drug; HPLC ICP MS; Leishmaniasis; Speciation

Indexed keywords

DPP; DRUG; HPLC ICP MS; LEISHMANIASIS; SPECIATION;

EID: 84870906828     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6427-3     Document Type: Article
Times cited : (23)

References (24)
  • 4
    • 84856101986 scopus 로고    scopus 로고
    • Use of antimony in the treatment of leishmaniasis: Current status and future directions
    • doi:10.4061/2011/571242
    • Haldar AK, Sen P, Roy S (2011) Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biol Int. doi:10.4061/2011/571242
    • (2011) Mol Biol Int.
    • Haldar, A.K.1    Sen, P.2    Roy, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.